Decreased Soluble Guanylate Cyclase Contributes to Cardiac Dysfunction Induced by Chronic Doxorubicin Treatment in Mice

Aims: The use of doxorubicin, a potent chemotherapeutic agent, is limited by cardiotoxicity. We tested the hypothesis that decreased soluble guanylate cyclase (sGC) enzyme activity contributes to the development of doxorubicin-induced cardiotoxicity. Results: Doxorubicin administration (20 mg/kg, in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antioxid Redox Signal
Main Authors: Vandenwijngaert, Sara, Swinnen, Melissa, Walravens, Ann-Sophie, Beerens, Manu, Gillijns, Hilde, Caluwé, Ellen, Tainsh, Robert E., Nathan, Daniel I., Allen, Kaitlin, Brouckaert, Peter, Bartunek, Jozef, Scherrer-Crosbie, Marielle, Bloch, Kenneth D., Bloch, Donald B., Janssens, Stefan P., Buys, Emmanuel S.
Formato: Artigo
Idioma:Inglês
Publicado em: Mary Ann Liebert, Inc. 2017
Assuntos:
Forum Original Research CommunicationsNO Receptor – Part II of II (A. Beuve, Ed.)
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5278809/
https://ncbi.nlm.nih.gov/pubmed/27505125
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/ars.2015.6542
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados